| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/02/2000 | CA2069961C Method and compositions for inhibition of disorders associated with oxidative damage |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 05/02/2000 | CA2020838C Hemoregulatory peptides |
| 05/02/2000 | CA2006267C Method of treating herpesviruses |
| 05/02/2000 | CA2004784C Anti-aids virus agent 2-amino-6-chlorpurine-9-.beta.-2,'3'-dideoxyribofuranoside |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023592A2 Minimal promoters and uses thereof |
| 04/27/2000 | WO2000023575A1 Ups (ugc) |
| 04/27/2000 | WO2000023574A2 Hepatitis a vaccines |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023472A2 Interferon-beta fusion proteins and uses |
| 04/27/2000 | WO2000023468A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES |
| 04/27/2000 | WO2000023465A2 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | WO2000023457A1 Adenine derivatives |
| 04/27/2000 | WO2000023454A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 04/27/2000 | WO2000023448A1 Novel pterin antineoplastic agents |
| 04/27/2000 | WO2000023430A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 04/27/2000 | WO2000023407A2 Ureido-thiobutyric acid derivatives as ppar-agonists |
| 04/27/2000 | WO2000023117A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023105A2 Adjuvant systems and vaccines |
| 04/27/2000 | WO2000023104A1 Freeze-dried hepatitis a attenuated live vaccine and its stabilizer |
| 04/27/2000 | WO2000023103A1 Viral mastitis |
| 04/27/2000 | WO2000023101A1 Methods for treating sepsis |
| 04/27/2000 | WO2000023078A1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000023051A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | WO2000023045A1 Pharmaceutical composition with gastric residence and controlled release |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | WO2000004920A3 Method of vaccination of newly hatched poultry |
| 04/27/2000 | WO2000004919A3 Live attenuated salmonella vaccines to control avian pathogens |
| 04/27/2000 | WO2000004141A3 Use of nucleic acid molecules as antiviral agents |
| 04/27/2000 | WO2000000618A3 Polyketides and their synthesis |
| 04/27/2000 | WO1999057271A9 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19847142A1 Diagnosing borelliosis by detecting specific antibodies, using new Borellia antigens expressed preferentially during infection and also useful as immunogens in vaccines |
| 04/27/2000 | CA2773698A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2348153A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | CA2347409A1 Human proteins stam2a and stam2b and cdnas encoding these molecules |
| 04/27/2000 | CA2347369A1 Minimal promoters and uses thereof |
| 04/27/2000 | CA2347250A1 Methods for treating sepsis |
| 04/27/2000 | CA2347108A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | CA2347099A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2347045A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/27/2000 | CA2346500A1 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | CA2343094A1 Interferon-beta fusion proteins and uses |
| 04/26/2000 | EP0995757A2 Bivalent inhibitors of the proteasome |
| 04/26/2000 | EP0995746A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 04/26/2000 | EP0995443A1 Composition for treating burn wounds, skin abrasions and herpes |
| 04/26/2000 | EP0995120A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents |
| 04/26/2000 | EP0994949A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 04/26/2000 | EP0994904A2 AMINO ACID SEQUENCES FOR THERAPEUTICAL AND PROPHYLACTIC APPLICATIONS TO DISEASES DUE TO $i(CLOSTRIDIUM DIFFICILE) TOXINS |
| 04/26/2000 | EP0994890A2 Benzimidazole derivatives |
| 04/26/2000 | EP0994889A2 Erythromycin a oxime solvates |
| 04/26/2000 | EP0994878A1 Quinolone carboxylic acid derivatives |
| 04/26/2000 | EP0994874A1 Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 04/26/2000 | EP0994730A2 LABELLED FACTOR XIIIa SUBSTRATES |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0994723A1 Methods of immunizing adults using anti-meningococcal vaccine compositions |
| 04/26/2000 | EP0994716A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 04/26/2000 | EP0994715A1 Difluoronucleoside phosphonic acids and derivatives thereof |
| 04/26/2000 | EP0994700A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 04/26/2000 | EP0994697A1 Rapamycin formulations for oral administration |
| 04/26/2000 | EP0983037A4 Antifungal nail lacquer and method using same |
| 04/26/2000 | EP0802913B1 IMIDAZO [4,5-c]QUINOLINE AMINES |
| 04/26/2000 | EP0787121B1 Legionella specific antibiotic, a microorganism producing the antibiotic and a process for producing the same |
| 04/26/2000 | EP0656945B1 Stress protein epitopes |
| 04/26/2000 | EP0656013B1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 04/26/2000 | EP0633930B1 In vitro generation of human dendritic cells |
| 04/26/2000 | EP0554381B2 Use of protective agents against reactive oxygen species |
| 04/26/2000 | EP0507872B1 The use of arginine as an immunostimulator |
| 04/26/2000 | CN1251614A New EIA test using non-dentured HIV antigen for early detection of HIV infection |
| 04/26/2000 | CN1251612A Novel compound |
| 04/26/2000 | CN1251611A USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 04/26/2000 | CN1251592A Nucleotide analog composation |
| 04/26/2000 | CN1251591A Antibacterial substituted 7-acylamino-3 (methylhydrazono) methyl-cephalosporins and intermediates |
| 04/26/2000 | CN1251590A Crystalline amine salt of cefdinir |
| 04/26/2000 | CN1251588A Novel 3,5 and/or 6 substituted analogues of swainsonine, process for their preparation and their use as therapeutic agents |
| 04/26/2000 | CN1251582A Asymmetric synthesis of benzoxazinones via new intermediates |
| 04/26/2000 | CN1251579A Compound and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 04/26/2000 | CN1251525A Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating AIDS |
| 04/26/2000 | CN1251308A Chinese medicine for quickly ard radically curing rabies |
| 04/26/2000 | CN1251295A External-use bathing lotion with antibiotic and anti-inflammatory functions |
| 04/26/2000 | CN1051767C Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 04/26/2000 | CN1051758C Anti-androgenic cyclo and bicycle alkenes |
| 04/25/2000 | US6054572 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 04/25/2000 | US6054567 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 04/25/2000 | US6054478 Antifungal sordaridin derivatives |
| 04/25/2000 | US6054465 Used to stimulate hematopoiesis and for the treatment of bacterial infectious diseases. |
| 04/25/2000 | US6054434 8a-azalides as veterinary antimicrobal agents |
| 04/25/2000 | US6054431 Anti-gram-positive bacterial methods and materials |
| 04/25/2000 | US6054296 66 kDa antigen from Borrelia |
| 04/25/2000 | US6054265 Screening assays for compounds that inhibit membrane fusion-associated events |
| 04/25/2000 | US6054143 Xylitol delivery |
| 04/25/2000 | US6054134 An immunogen which binds specifically to phosphatidylethanolamine, gangliotriaosylceramide and gangliotetraosylceramide; protecting susceptible mammals from diseases caused by bacterial influenzae pathogens |